PCV83 COMPARISON OF TREATMENT ADHERENCE AND PERSISTENCE WITH EDOXABAN VERSUS APIXABAN, DABIGATRAN, RIVAROXABAN, AND VITAMIN K ANTAGONIST IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN GERMANY: A PROPENSITY MATCHED COHORT STUDY

May 1, 2020, 00:00
10.1016/j.jval.2020.04.184
https://www.valueinhealthjournal.com/article/S1098-3015(20)30372-7/fulltext
Title : PCV83 COMPARISON OF TREATMENT ADHERENCE AND PERSISTENCE WITH EDOXABAN VERSUS APIXABAN, DABIGATRAN, RIVAROXABAN, AND VITAMIN K ANTAGONIST IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN GERMANY: A PROPENSITY MATCHED COHORT STUDY
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30372-7&doi=10.1016/j.jval.2020.04.184
First page :
Section Title :
Open access? : No
Section Order : 10036
Categories :
Tags :
Regions :
ViH Article Tags :